# Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer

> **NCT00031980** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 30 (actual)

## Conditions studied

- Anemia
- Leukemia
- Neutropenia
- Thrombocytopenia

## Interventions

- **DRUG:** cyclosporine

## Key facts

- **NCT ID:** NCT00031980
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031980, "Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00031980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*